These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 32184664)
1. Sal-Like Protein 4 Transcription Factor: A Significant Diagnostic Biomarker Involved in Childhood ALL Resistance and Relapse. Ohadi F; Rahgozar S; Ghodousi ES Cancer Manag Res; 2020; 12():1611-1619. PubMed ID: 32184664 [TBL] [Abstract][Full Text] [Related]
2. SALL4, a stem cell factor, affects the side population by regulation of the ATP-binding cassette drug transport genes. Jeong HW; Cui W; Yang Y; Lu J; He J; Li A; Song D; Guo Y; Liu BH; Chai L PLoS One; 2011 Apr; 6(4):e18372. PubMed ID: 21526180 [TBL] [Abstract][Full Text] [Related]
3. miR-324-3p and miR-508-5p expression levels could serve as potential diagnostic and multidrug-resistant biomarkers in childhood acute lymphoblastic leukemia. Zamani A; Fattahi Dolatabadi N; Houshmand M; Nabavizadeh N Leuk Res; 2021 Oct; 109():106643. PubMed ID: 34147937 [TBL] [Abstract][Full Text] [Related]
4. Dysregulation of miR-335-3p, targeted by NEAT1 and MALAT1 long non-coding RNAs, is associated with poor prognosis in childhood acute lymphoblastic leukemia. Pouyanrad S; Rahgozar S; Ghodousi ES Gene; 2019 Apr; 692():35-43. PubMed ID: 30639603 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-326 and microRNA-200c: Two novel biomarkers for diagnosis and prognosis of pediatric acute lymphoblastic leukemia. Ghodousi ES; Rahgozar S J Cell Biochem; 2018 Jul; 119(7):6024-6032. PubMed ID: 29630744 [TBL] [Abstract][Full Text] [Related]
6. The translational expression of ABCA2 and ABCA3 is a strong prognostic biomarker for multidrug resistance in pediatric acute lymphoblastic leukemia. Aberuyi N; Rahgozar S; Khosravi Dehaghi Z; Moafi A; Masotti A; Paolini A Onco Targets Ther; 2017; 10():3373-3380. PubMed ID: 28744141 [TBL] [Abstract][Full Text] [Related]
7. Acute lymphoblastic leukemia in children and SALL4 and BMI-1 gene expression. Hodeib H; El Amrousy D; Youssef A; Khedr R; Al-Asy H; Shabana A; Elnemr S; Abdelhai D Pediatr Res; 2023 Oct; 94(4):1510-1515. PubMed ID: 34782707 [TBL] [Abstract][Full Text] [Related]
8. mRNA expression profile of multidrug-resistant genes in acute lymphoblastic leukemia of children, a prognostic value for ABCA3 and ABCA2. Rahgozar S; Moafi A; Abedi M; Entezar-E-Ghaem M; Moshtaghian J; Ghaedi K; Esmaeili A; Montazeri F Cancer Biol Ther; 2014 Jan; 15(1):35-41. PubMed ID: 24145140 [TBL] [Abstract][Full Text] [Related]
9. The Hedgehog signal transducer Sheybani Z; Rahgozar S; Ghodousi ES Cancer Manag Res; 2019; 11():7621-7630. PubMed ID: 31616178 [TBL] [Abstract][Full Text] [Related]
10. The differential expression pattern of the BMI-1, SALL4 and ABCA3 genes in myeloid leukemia. Shen Q; Liu S; Hu J; Chen S; Yang L; Li B; Wu X; Ma Y; Yang J; Ma Y; Li Y Cancer Cell Int; 2012 Oct; 12(1):42. PubMed ID: 23067006 [TBL] [Abstract][Full Text] [Related]
12. [Detection of SALL4 mRNA expression in leukemia by real-time fluorescent quantitative PCR]. Duan MX; Bi CX; Chen H; Wang N; Li SJ; Xiao XG; Ma XL; Yuan H Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1153-6. PubMed ID: 24156424 [TBL] [Abstract][Full Text] [Related]
13. [Expression of SALL4 and BMI-1 mRNA in acute leukemia]. Tang P; Sun H; Liu YF; Wang GY; Yin YF Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Dec; 16(6):1271-4. PubMed ID: 19099625 [TBL] [Abstract][Full Text] [Related]
14. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma. Zeng SS; Yamashita T; Kondo M; Nio K; Hayashi T; Hara Y; Nomura Y; Yoshida M; Hayashi T; Oishi N; Ikeda H; Honda M; Kaneko S J Hepatol; 2014 Jan; 60(1):127-34. PubMed ID: 24012616 [TBL] [Abstract][Full Text] [Related]
15. The new advance of SALL4 in cancer: Function, regulation, and implication. Abouelnazar FA; Zhang X; Wang M; Zhang J; Yu D; Zang X; Zhang J; Li Y; Xu J; Yang Q; Zhou Y; Tang H; Wang Y; Gu J; Zhang X J Clin Lab Anal; 2023 May; 37(9-10):e24927. PubMed ID: 37337914 [TBL] [Abstract][Full Text] [Related]
16. Comparison of minimal residual disease (MRD) monitoring by WT1 quantification between childhood acute myeloid leukemia and acute lymphoblastic leukemia. Zhang R; Yang JY; Sun HQ; Jia H; Liao J; Shi YJ; Li G Eur Rev Med Pharmacol Sci; 2015; 19(14):2679-88. PubMed ID: 26221900 [TBL] [Abstract][Full Text] [Related]
18. [A tal-1 deletion as real-time quantitative polymerase chain reaction target for detection of minimal residual disease in T-lineage acute lymphoblastic leukemia]. Wang L; Zhang LP; Li ZG; Cheng YF; Tian KG; Lu AD Zhonghua Er Ke Za Zhi; 2005 Mar; 43(3):170-3. PubMed ID: 15833185 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL. Ghodousi ES; Aberuyi N; Rahgozar S Jpn J Clin Oncol; 2020 Jun; 50(6):671-678. PubMed ID: 32129446 [TBL] [Abstract][Full Text] [Related]
20. Expression pattern and prognostic implication of SALL4 gene in myeloid leukemias: a case-control study. Farawela HM; Zawam HM; Al-Wakeel HA; El-Nagdy MH; El-Refaey FA; Abdel-Rahman HA Scand J Clin Lab Invest; 2019; 79(1-2):65-70. PubMed ID: 30638095 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]